Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.
Xie JY, Chew LA, Yang X, Wang Y, Qu C, Wang Y, Federici LM, Fitz SD, Ripsch MS, Due MR, Moutal A, Khanna M, White FA, Vanderah TW, Johnson PL, Porreca F, Khanna R.
Xie JY, et al.
Pain. 2016 Sep;157(9):2124-2140. doi: 10.1097/j.pain.0000000000000628.
Pain. 2016.
PMID: 27537210
Free PMC article.